307 related articles for article (PubMed ID: 11413168)
1. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.
Coscoy L; Ganem D
J Clin Invest; 2001 Jun; 107(12):1599-606. PubMed ID: 11413168
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein.
Ishido S; Choi JK; Lee BS; Wang C; DeMaria M; Johnson RP; Cohen GB; Jung JU
Immunity; 2000 Sep; 13(3):365-74. PubMed ID: 11021534
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins block distinct steps in transendothelial migration of effector memory CD4+ T cells by targeting different endothelial proteins.
Manes TD; Hoer S; Muller WA; Lehner PJ; Pober JS
J Immunol; 2010 May; 184(9):5186-92. PubMed ID: 20357254
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication.
Brulois K; Toth Z; Wong LY; Feng P; Gao SJ; Ensser A; Jung JU
J Virol; 2014 Aug; 88(16):9335-49. PubMed ID: 24899205
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5.
Li Q; Means R; Lang S; Jung JU
J Virol; 2007 Mar; 81(5):2117-27. PubMed ID: 17166914
[TBL] [Abstract][Full Text] [Related]
6. The Kaposi's sarcoma-associated herpesvirus K5 E3 ubiquitin ligase modulates targets by multiple molecular mechanisms.
Means RE; Lang SM; Jung JU
J Virol; 2007 Jun; 81(12):6573-83. PubMed ID: 17409151
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus ubiquitin ligases downregulate cell surface expression of l-selectin.
Kajikawa M; Imaizumi N; Machii S; Nakamura T; Harigane N; Kimura M; Miyano K; Ishido S; Kanamoto T
J Gen Virol; 2021 Nov; 102(11):. PubMed ID: 34726593
[TBL] [Abstract][Full Text] [Related]
8. Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.
Nicol SM; Sabbah S; Brulois KF; Jung JU; Bell AI; Hislop AD
J Virol; 2016 Apr; 90(8):3849-3859. PubMed ID: 26819313
[TBL] [Abstract][Full Text] [Related]
9. Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2.
Shrestha P; Davis DA; Jaeger HK; Stream A; Aisabor AI; Yarchoan R
PLoS Pathog; 2021 Jan; 17(1):e1009091. PubMed ID: 33411730
[TBL] [Abstract][Full Text] [Related]
10. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.
Ishido S; Wang C; Lee BS; Cohen GB; Jung JU
J Virol; 2000 Jun; 74(11):5300-9. PubMed ID: 10799607
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4+ T cells.
Barcy S; Corey L
J Immunol; 2001 May; 166(10):6242-9. PubMed ID: 11342647
[TBL] [Abstract][Full Text] [Related]
13. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.
Bartee E; McCormack A; Früh K
PLoS Pathog; 2006 Oct; 2(10):e107. PubMed ID: 17238276
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus.
Mansouri M; Viswanathan K; Douglas JL; Hines J; Gustin J; Moses AV; Früh K
J Virol; 2009 Oct; 83(19):9672-81. PubMed ID: 19605472
[TBL] [Abstract][Full Text] [Related]
15. The intertransmembrane region of Kaposi's sarcoma-associated herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation.
Kajikawa M; Li PC; Goto E; Miyashita N; Aoki-Kawasumi M; Mito-Yoshida M; Ikegaya M; Sugita Y; Ishido S
J Virol; 2012 May; 86(9):5288-96. PubMed ID: 22379101
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.
Thomas M; Boname JM; Field S; Nejentsev S; Salio M; Cerundolo V; Wills M; Lehner PJ
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1656-61. PubMed ID: 18230726
[TBL] [Abstract][Full Text] [Related]
17. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
18. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step.
Morel AS; Quaratino S; Douek DC; Londei M
Eur J Immunol; 1997 Jan; 27(1):26-34. PubMed ID: 9021994
[TBL] [Abstract][Full Text] [Related]
19. Microvilli structures on B lymphocytes: inducible functional domains?
Greicius G; Westerberg L; Davey EJ; Buentke E; Scheynius A; Thyberg J; Severinson E
Int Immunol; 2004 Feb; 16(2):353-64. PubMed ID: 14734621
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
